Decoy Therapeutics Inc. Other Non-Current Assets
Decoy Therapeutics Inc. (DCOY) had Other Non-Current Assets of $28.77 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-12
- 2026-06-30: Other Assets, Noncurrent $28.77K.
- 2026-03-31: Other Assets, Noncurrent $29.88K.
- 2025-12-31: Other Assets, Noncurrent $30.99K.
- 2025-09-30: Other Assets, Noncurrent $32.09K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $28.77K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $29.88K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $30.99K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $32.09K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $33.20K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $34.31K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $35.41K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $36.52K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $39.93K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $53.39K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $66.85K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $80.44K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $99.05K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $114.85K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $130.50K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $146.46K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $162.42K 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $170.91K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $193.87K 10-K · filed 2023-03-27 | $185.99K 10-K · filed 2022-03-25 |
| 2021-09-30 | $201.39K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $216.79K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $232.03K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $247.11K 10-K · filed 2022-03-25 | |
| 2020-09-30 | $262.51K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $279.77K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $293.15K 10-Q/A · filed 2020-05-15 | |
| 2019-12-31 | $308.67K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $324.51K 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $195.43K 10-K · filed 2020-03-23 | |
| 2017-12-31 | $0.00 10-K · filed 2018-03-07 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $64.80K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $64.80K 10-K · filed 2018-03-07 | |
| 2016-09-30 | $64.80K 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $64.80K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $64.80K 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-08 | |
| 2015-09-30 | $85.20K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $85.20K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $85.20K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $50.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |